The Latin America, Middle East and Africa Magnetoencephalography Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).
MEG recordings may be made on people when they are asleep. MEG does not generate any operational noise, unlike fMRI. In order to get accurate results from an fMRI scan, the patient must remain completely still during the recording process. However, the person need not be completely still to obtain accurate results from a MEG scan.
In conclusion, magnetic field electroencephalography (MEG) provides us with temporal features regarding brain activity with an accuracy of less than one millisecond, in contrast to functional magnetic resonance imaging (fMRI), which offers only limited temporal information. EEG, a technology complementary to MEG in terms of capturing brain activity, gives a spatial localization of neural activities; however, MEG provides more precise spatial localization of neural activities. Co-registration of EEG and MEG data is possible because of the equipment at the I-LABS MEG Brain Imaging Center.
It is possible to show the magnetic source on the structural MRI by using fiducial markers, structural magnetic resonance imaging (MRI), and core registration. This kind of imaging is known as magnetic source imaging. Imaging of magnetic sources may be used to study both naturally occurring magnetic activity and magnetic fields that are caused by external events. The most common use for MEG is for evaluating interictal epileptiform activity; in this way, it contributes to defining the irritative zone.
The population's health problems in the Middle East have been directly impacted by the numerous significant changes that have taken place in the region, just as they have in other nations throughout the globe. The World Health Organization (WHO) has released research on dementia that reveals an alarming growth in the frequency of dementia throughout the Middle Eastern area, which may increase 125% by the year 2050. Furthermore, in order to develop Dubai as a centre of excellence for healthcare in the area, the government of the UAE is working toward increasing the number of tourists who come to the UAE for medical treatment. In the LAMEA area, the demand for magnetoencephalography would likely increase as a result of all of these factors.
The Brazil market dominated the LAMEA Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $5,753 Thousands by 2028. The Argentina market is showcasing a CAGR of 7.7% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 6.9% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
MEG recordings may be made on people when they are asleep. MEG does not generate any operational noise, unlike fMRI. In order to get accurate results from an fMRI scan, the patient must remain completely still during the recording process. However, the person need not be completely still to obtain accurate results from a MEG scan.
In conclusion, magnetic field electroencephalography (MEG) provides us with temporal features regarding brain activity with an accuracy of less than one millisecond, in contrast to functional magnetic resonance imaging (fMRI), which offers only limited temporal information. EEG, a technology complementary to MEG in terms of capturing brain activity, gives a spatial localization of neural activities; however, MEG provides more precise spatial localization of neural activities. Co-registration of EEG and MEG data is possible because of the equipment at the I-LABS MEG Brain Imaging Center.
It is possible to show the magnetic source on the structural MRI by using fiducial markers, structural magnetic resonance imaging (MRI), and core registration. This kind of imaging is known as magnetic source imaging. Imaging of magnetic sources may be used to study both naturally occurring magnetic activity and magnetic fields that are caused by external events. The most common use for MEG is for evaluating interictal epileptiform activity; in this way, it contributes to defining the irritative zone.
The population's health problems in the Middle East have been directly impacted by the numerous significant changes that have taken place in the region, just as they have in other nations throughout the globe. The World Health Organization (WHO) has released research on dementia that reveals an alarming growth in the frequency of dementia throughout the Middle Eastern area, which may increase 125% by the year 2050. Furthermore, in order to develop Dubai as a centre of excellence for healthcare in the area, the government of the UAE is working toward increasing the number of tourists who come to the UAE for medical treatment. In the LAMEA area, the demand for magnetoencephalography would likely increase as a result of all of these factors.
The Brazil market dominated the LAMEA Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $5,753 Thousands by 2028. The Argentina market is showcasing a CAGR of 7.7% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 6.9% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
Scope of the Study
Market Segments Covered in the Report:
By Application
- Clinical
- Epilepsy
- Dementia
- Autism
- Stroke
- Multiple Sclerosis
- Schizophrenia
- Others
- Research
By End-use
- Hospitals
- Academic & Research Institutes
- Imaging centres
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc
- MEGIN OY
- CTF MEG Neuro Innovations, Inc
- Cerca Magnetics Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Magnetoencephalography Market, by Application
1.4.2 LAMEA Magnetoencephalography Market, by End-use
1.4.3 LAMEA Magnetoencephalography Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Magnetoencephalography Market by Application
3.1 LAMEA Clinical Market by Country
3.2 LAMEA Magnetoencephalography Market by Clinical Type
3.2.1 LAMEA Epilepsy Market by Country
3.2.2 LAMEA Dementia Market by Country
3.2.3 LAMEA Autism Market by Country
3.2.4 LAMEA Stroke Market by Country
3.2.5 LAMEA Multiple Sclerosis Market by Country
3.2.6 LAMEA Schizophrenia Market by Country
3.2.7 LAMEA Others Market by Country
3.3 LAMEA Research Market by Country
Chapter 4. LAMEA Magnetoencephalography Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Academic & Research Institutes Market by Country
4.3 LAMEA Imaging centres Market by Country
Chapter 5. LAMEA Magnetoencephalography Market by Country
5.1 Brazil Magnetoencephalography Market
5.1.1 Brazil Magnetoencephalography Market by Application
5.1.1.1 Brazil Magnetoencephalography Market by Clinical Type
5.1.2 Brazil Magnetoencephalography Market by End-use
5.2 Argentina Magnetoencephalography Market
5.2.1 Argentina Magnetoencephalography Market by Application
5.2.1.1 Argentina Magnetoencephalography Market by Clinical Type
5.2.2 Argentina Magnetoencephalography Market by End-use
5.3 UAE Magnetoencephalography Market
5.3.1 UAE Magnetoencephalography Market by Application
5.3.1.1 UAE Magnetoencephalography Market by Clinical Type
5.3.2 UAE Magnetoencephalography Market by End-use
5.4 Saudi Arabia Magnetoencephalography Market
5.4.1 Saudi Arabia Magnetoencephalography Market by Application
5.4.1.1 Saudi Arabia Magnetoencephalography Market by Clinical Type
5.4.2 Saudi Arabia Magnetoencephalography Market by End-use
5.5 South Africa Magnetoencephalography Market
5.5.1 South Africa Magnetoencephalography Market by Application
5.5.1.1 South Africa Magnetoencephalography Market by Clinical Type
5.5.2 South Africa Magnetoencephalography Market by End-use
5.6 Nigeria Magnetoencephalography Market
5.6.1 Nigeria Magnetoencephalography Market by Application
5.6.1.1 Nigeria Magnetoencephalography Market by Clinical Type
5.6.2 Nigeria Magnetoencephalography Market by End-use
5.7 Rest of LAMEA Magnetoencephalography Market
5.7.1 Rest of LAMEA Magnetoencephalography Market by Application
5.7.1.1 Rest of LAMEA Magnetoencephalography Market by Clinical Type
5.7.2 Rest of LAMEA Magnetoencephalography Market by End-use
Chapter 6. Company Profiles
6.1 Compumedics Limited
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Partnerships, Collaborations and Agreements:
6.2 Ricoh Company, Ltd
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 FieldLine, Inc.
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Product Launches and Product Expansions:
6.4 MEGIN OY
6.4.1 Company Overview
6.5 CTF MEG Neuro Innovations, Inc.
6.5.1 Company Overview
6.6 Cerca Magnetics Limited
6.6.1 Company Overview
Companies Mentioned
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc.
- MEGIN OY
- CTF MEG Neuro Innovations, Inc.
- Cerca Magnetics Limited
Methodology
LOADING...
